The stock may react positively due to the strong profitability turnaround, buyback authorization, and sustained guidance despite macro headwinds. Traders should monitor Q1 2026 revenue trends for signs of deceleration given management's caution on customer spending.
Price Chart
Executive Summary
OptimizeRx reported strong Q4 and full-year 2025 results with record revenue of $109.4M (+19% YoY), record net income of $5.1M (vs. $20.1M loss last year), and adjusted EBITDA doubling to $24.3M. The company achieved profitability and Rule of 40 status, announced a $10M share buyback, and maintained 2026 revenue guidance at $109M–$114M despite near-term headwinds from market volatility.
Key Financial Metrics
Key Facts
- Q4 revenue was $32.2M, flat YoY; full-year revenue grew 19% to $109.4M
- GAAP net income was $5.1M in 2025 vs. a $20.1M net loss in 2024
- Adjusted EBITDA doubled to $24.3M in 2025 from $11.7M in 2024
- Company achieved Rule of 40 profitability benchmark
- Board authorized $10M share repurchase program
- 2026 guidance: revenue $109M–$114M, adjusted EBITDA $21M–$25M
- Cash balance increased to $23.4M from $13.4M in prior year
Financial Impact
Revenue up $17.3M YoY, net income improved by $25.2M, EBITDA up $12.6M; $10M buyback represents ~6.8% of current market cap
Risk Factors
- Management noted near-term headwinds from customer spending caution due to MFN pricing uncertainty
- 2026 revenue guidance midpoint ($111.5M) implies flat to slight growth vs. 2025 actual ($109.4M), suggesting a slowdown
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3250639 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Press Release | $9.15 | awaiting T+20 | — | $9.07 (−0.87%) |
Oct 21, 2026 5d ago | SC 13G/A | $9.37 | awaiting T+20 | — | $9.07 (−3.20%) |
Sep 22, 2026 4w ago | Institutional Cluster | $7.62 $8.93 | ▲ +17.19% | ▲ +17.75% | $9.07 (+19.03%) |
Aug 12, 2026 10w ago | Press Release | $8.78 $7.29 | ▼ −16.97% | ▼ −15.22% | $9.07 (+3.30%) |
Jun 12, 2026 19w ago | 8-K | $5.32 $6.55 | ▲ +23.12% | ▲ +23.87% | $9.07 (+70.49%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.28 $6.28 | ▲ +18.94% | ▲ +17.05% | $9.07 (+71.78%) |
Jun 5, 2026 20w ago | 8-K | $5.05 $6.35 | ▲ +25.74% | ▲ +24.11% | $9.07 (+79.60%) |
Jun 1, 2026 21w ago | DEFA14A | $5.38 $5.72 | ▲ +6.32% | ▲ +7.62% | $9.07 (+68.59%) |
May 21, 2026 22w ago | Press Release | $4.94 $4.70 | ▼ −4.86% | ▼ −5.19% | $9.07 (+83.60%) |
May 12, 2026 23w ago | Press Release | $4.92 $5.28 | ▲ +7.32% | ▲ +7.93% | $9.07 (+84.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers